Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris (Q39224359)

10 September 2017

title

Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris (English)

1 reference

10 September 2017

1 reference

Pichia pastoris

1 reference

Lin Wan

1

1 reference

10 September 2017

Shengyun Zhu

2

1 reference

10 September 2017

Jian Zhu

3

1 reference

10 September 2017

Hao Yang

4

1 reference

10 September 2017

Shengfu Li

5

1 reference

10 September 2017

Youping Li

6

1 reference

10 September 2017

Jingqiu Cheng

7

1 reference

10 September 2017

Xiaofeng Lu

8

1 reference

10 September 2017

language of work or name

English

0 references

publication date

19 December 2012

1 reference

Applied Microbiology and Biotechnology

10 September 2017

published in

1 reference

10 September 2017

volume

97

1 reference

10 September 2017

issue

9

1 reference

10 September 2017

page(s)

3855-3863

1 reference

Strategies and challenges for the next generation of therapeutic antibodies

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Monoclonal antibodies in MS: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Antibody therapy for Adult T-cell leukemia-lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Optimizing therapeutic antibody function: progress with Fc domain engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Strategies to extend plasma half-lives of recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Engineered therapeutic antibodies with improved effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Emerging drugs for uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Antibodies and gene therapy: teaching old 'magic bullets' new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Rise and fall of an anti-MUC1 specific antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

High-level expression of a functional humanized single-chain variable fragment antibody against CD25 in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Production and characterization of LEA29Y, a variant of cytotoxic T-lymphocyte antigen 4-immunoglobulin, in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-012-4632-9

10.1007/S00253-012-4632-9

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference